03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Diabetes
Giedre Cepukaityte
Cognitive neuroscientist at tech company Thymia
press citations on 1 topic since 28 Sept 2026 · last quoted 28 Sept 2026
02 Quoted on · 1 of 29 topics
Giedre Cepukaityte: key facts
- Kind of voice
- Sector leader
- Role
- Cognitive neuroscientist at tech company Thymia
- Quoted on
- Diabetes
- Tracked press citations
- 2
- Most recently quoted
- 28 Sept 2026
04 The signal · where Giedre Cepukaityte sits on diabetes
Ranked 24= of 100 voices quoted in the press on diabetes, level with 33 others on 2 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK15 - 2
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)11 - 3=
Parth NarendranAcademicProfessor of Diabetes Medicine; Honorary Consultant Physician (leads the Type 1 Diabetes clinical service at the Queen Elizabeth Hospital Birmingham), University of Birmingham8 - 24=Sean NewtonSector leaderHealthcare engagement and systems change manager, Diabetes UK Cymru2
- 24=Professor Chantal MathieuAcademicPresident of the European Association for the Study of Diabetes2
- 24=Giedre CepukaityteSector leaderCognitive neuroscientist at tech company Thymia2
- 24=Kenneth CusterSector leaderPresident of Lilly's cardiometabolic health unit2
- 24=Janet McGillAcademicProfessor of Medicine in the Division of Endocrinology, Metabolism, and Lipid Research at Washington University School of Medicine in St. Louis, and Co-Chair of the study's Executive Committee2
Showing the leaders and the ranks around 24=, of 100 voices · See every voice on the topic →
05 On the record · press
What Giedre Cepukaityte has said
- aol.co.uk1
- mirror.co.uk1
Where Giedre Cepukaityte has been quoted
- 01Type 2 diabetes symptoms: Subtle change to your voice could reveal your risk to new AI programme - AOLaol.co.uk · 28 Sept 2026
- 02Subtle change in your voice could indicate type 2 diabetes risk to AI programmemirror.co.uk · 28 Sept 2026
Verbatim
“This has the potential to change what screening looks like.”
“This is the largest real-world study of speech-based screening for type 2 diabetes to date which also checks the model's predictions against blood test results as well as against what people reported about their own diagnosis. Those flagged up as higher risk by the model had blood results to match.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Could Cell and Gene Therapies Provide a One-and-Done Treatment for Obesity?technologynetworks.com
- First UK patient treated with NICE approved TeplizumabUniversity of Birmingham
- ICB refuses to fund GPs for transitioning patients from discontinued Levemir - Pulse Todaypulsetoday.co.uk
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.